BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warren TK, Whitehouse CA, Wells J, Welch L, Charleston JS, Heald A, Nichols DK, Mattix ME, Palacios G, Kugleman JR, Iversen PL, Bavari S. Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques. PLoS Negl Trop Dis 2016;10:e0004456. [PMID: 26901785 DOI: 10.1371/journal.pntd.0004456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ristanović ES, Kokoškov NS, Crozier I, Kuhn JH, Gligić AS. A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967. Microbiol Mol Biol Rev 2020;84:e00095-19. [PMID: 32404328 DOI: 10.1128/MMBR.00095-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Blair PW, Keshtkar-Jahromi M, Psoter KJ, Reisler RB, Warren TK, Johnston SC, Goff AJ, Downey LG, Bavari S, Cardile AP. Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis. Viruses 2018;10:E658. [PMID: 30469360 DOI: 10.3390/v10110658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Boldescu V, Behnam MAM, Vasilakis N, Klein CD. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat Rev Drug Discov 2017;16:565-86. [PMID: 28473729 DOI: 10.1038/nrd.2017.33] [Cited by in Crossref: 147] [Cited by in F6Publishing: 122] [Article Influence: 29.4] [Reference Citation Analysis]
4 Nan Y, Zhang YJ. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds. Front Microbiol 2018;9:750. [PMID: 29731743 DOI: 10.3389/fmicb.2018.00750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
5 Kortepeter MG, Dierberg K, Shenoy ES, Cieslak TJ; Medical Countermeasures Working Group of the National Ebola Training and Education Center's (NETEC) Special Pathogens Research Network (SPRN). Marburg virus disease: A summary for clinicians. Int J Infect Dis 2020;99:233-42. [PMID: 32758690 DOI: 10.1016/j.ijid.2020.07.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Miraglia CM. Marburgviruses: An Update. Lab Med 2019;50:16-28. [PMID: 30085179 DOI: 10.1093/labmed/lmy046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, Garza NL, Donnelly G, Cazares LH, Nuss J, Soloveva V, Koistinen KA, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Res 2018;151:97-104. [PMID: 29289666 DOI: 10.1016/j.antiviral.2017.12.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
8 Araújo D, Azevedo NM, Barbosa A, Almeida C, Rodrigues ME, Henriques M, Silva S. Application of 2'-OMethylRNA' Antisense Oligomer to Control Candida albicans EFG1 Virulence Determinant. Mol Ther Nucleic Acids 2019;18:508-17. [PMID: 31671344 DOI: 10.1016/j.omtn.2019.09.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Juliano RL. The delivery of therapeutic oligonucleotides. Nucleic Acids Res 2016;44:6518-48. [PMID: 27084936 DOI: 10.1093/nar/gkw236] [Cited by in Crossref: 432] [Cited by in F6Publishing: 410] [Article Influence: 72.0] [Reference Citation Analysis]
10 Chery J, Petri A, Wagschal A, Lim SY, Cunningham J, Vasudevan S, Kauppinen S, Näär AM. Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1. Nucleic Acid Ther 2018;28:273-84. [PMID: 30133337 DOI: 10.1089/nat.2018.0722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Shadid M, Badawi M, Abulrob A. Antisense oligonucleotides: absorption, distribution, metabolism, and excretion. Expert Opin Drug Metab Toxicol 2021;:1-12. [PMID: 34643122 DOI: 10.1080/17425255.2021.1992382] [Reference Citation Analysis]
12 Araújo D, Mil-Homens D, Rodrigues ME, Henriques M, Jørgensen PT, Wengel J, Silva S. Antisense locked nucleic acid gapmers to control Candida albicans filamentation. Nanomedicine 2022;39:102469. [PMID: 34606999 DOI: 10.1016/j.nano.2021.102469] [Reference Citation Analysis]
13 Cross RW, Mire CE, Feldmann H, Geisbert TW. Post-exposure treatments for Ebola and Marburg virus infections. Nat Rev Drug Discov 2018;17:413-34. [DOI: 10.1038/nrd.2017.251] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 14.3] [Reference Citation Analysis]
14 Coffin KM, Liu J, Warren TK, Blancett CD, Kuehl KA, Nichols DK, Bearss JJ, Schellhase CW, Retterer CJ, Weidner JM, Radoshitzky SR, Brannan JM, Cardile AP, Dye JM, Palacios G, Sun MG, Kuhn JH, Bavari S, Zeng X. Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors. Cell Host Microbe 2018;24:405-416.e3. [PMID: 30173956 DOI: 10.1016/j.chom.2018.08.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]